Category

Daily Briefs

Daily Brief Health Care: China Resources Pharmaceutical, Haw Par Corp, Grifols SA, Kelun Biotech, X4 Pharmaceuticals , Biora Therapeutics , Revelation Biosciences , Aethlon Medical and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Quiddity Leaderboard for Hang Seng Index Sep 24: New Economy? Clean Energy? or Shipping?
  • Haw Par Corp (HPAR SP): Unleash the Tiger, Unlock Shareholder Value
  • (Desperate) Takeover Bid in the Making
  • Kelun-Biotech IPO Lock-Up Expiry – Strong Performance Leaves Pre-IPO Investors with Large Gains
  • XFOR: Positive Interim Data from Ongoing Phase 2 Trial of Mavorixafor in Chronic Neutropenia Patients
  • BIOR: BT-600 Topline
  • REVB: Positive Results Set Stage for Next Step
  • Depending on how long it takes medical venues to review the Hemopurifier data & potentially approve moving forward


Quiddity Leaderboard for Hang Seng Index Sep 24: New Economy? Clean Energy? or Shipping?

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at a group of names with reasonably high likelihood of being involved in index changes for the Hang Seng Index in September 2024.
  • The index changes for the September 2024 index rebal will be announced on 16th August 2024.
  • The HSI selection process is highly subjective and does not follow clear-cut rules. This insight is simply an attempt to provide readers with an overall understanding of the possible scenarios.

Haw Par Corp (HPAR SP): Unleash the Tiger, Unlock Shareholder Value

By Devi Subhakesan

  • Haw Par Corp (HPAR SP), with a rich investment portfolio and an attractive consumer health care business, trades at 4% dividend yield but at a steep discount to SOTP value.
  • The recent rise in share price of UOB (UOB SP) , where it holds a 4.5% stake, has widened this discount.
  • We believe the management can unlock immense value for share holders by de-merging the consumer healthcare business and publicly listing it.

(Desperate) Takeover Bid in the Making

By Jesus Rodriguez Aguilar

  • Grifols’ founding families and Brookfield ask the Board for the necessary information to evaluate an offer for 100% of Grifols SA (GRF SM). The CNMV has halted trading in the shares.
  • Grifols is worth €5.5 billion, after plummeting 39% in 2024. The deal smacks of desperation from the founding families, worried not to lose control of the company to debt holders. 
  • There should be a minimum premium to guarantee offer success, at least 15% to current share price (maybe even 30%). B shares are protected in case of takeover.

Kelun-Biotech IPO Lock-Up Expiry – Strong Performance Leaves Pre-IPO Investors with Large Gains

By Sumeet Singh

  • Kelun Biotech (KB) raised around US$170m in its IPO in July 2023, the lockup on its pre-IPO shareholders is set to expire soon.
  • KB is a China-based integrated innovative biopharmaceutical company. It has accumulated more than ten years of experience in antibody drug conjugates (ADC) development.
  • In this note, we talk about the upcoming lock-up expiry and possible deal dynamics.

XFOR: Positive Interim Data from Ongoing Phase 2 Trial of Mavorixafor in Chronic Neutropenia Patients

By Zacks Small Cap Research

  • On June 27, 2024, X4 Pharmaceuticals, Inc. (XFOR) announced positive interim results from the company’s ongoing Phase 2 trial of mavorixafor in patients with chronic neutropenia (CN).
  • The data showed that treatment with mavorixafor, as either a monotherapy or in combination with granulocyte colony-stimulating factor (G-CSF) was generally well tolerated and led to durable increases in patients’ absolute neutrophil counts.
  • The company also announced that it has begun screening patients for enrollment into the Phase 3 clinical trial of mavorixafor in people with congenital, acquired primary immune, or idiopathic CN who are experiencing recurrent and/or serious infections.

BIOR: BT-600 Topline

By Zacks Small Cap Research

  • Biora is a drug-device company developing smart pills for GI diseases and enabling oral delivery of biologics.
  • Its pipeline features two assets: NaviCap, for targeted drug delivery in GI diseases & BioJet, for oral delivery of biologics.
  • NaviCap’s BT-600 trial has reported its SAD & MAD topline & will advance to a Phase Ib. BioJet is on the cusp of a deal & may advance into the clinic through the efforts of pharma partners.

REVB: Positive Results Set Stage for Next Step

By Zacks Small Cap Research

  • Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of phosphorylated hexaacyl disaccharide (PHAD) and its effect on the innate immune system.
  • The company announced data from its Phase 1 clinical study of its Gemini treatment.
  • These results were extremely positive and represent a major step forward for Revelation.

Depending on how long it takes medical venues to review the Hemopurifier data & potentially approve moving forward

By Zacks Small Cap Research

  • Depending on how long it takes medical venues to review the Hemopurifier data & potentially approve moving forward, we believe clinical efforts could begin in 2H24.
  • AEMD had cash of about $9.1M as of June 25, 2024, to support its efforts, following a recent capital raise.
  • The company also believes it has a sufficient supply of Hemopurifiers for its planned oncology trials.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Mid-America Apartment Communit, Seazen (Formerly Future Land) and more

By | Daily Briefs, Financials

In today’s briefing:

  • Mid-America Apt Cmntys Inc (MAA.PI) – Monday, Apr 8, 2024
  • Morning Views Asia: China Jinmao Holdings


Mid-America Apt Cmntys Inc (MAA.PI) – Monday, Apr 8, 2024

By Value Investors Club

  • Public market investor has been investing in multifamily REITs for over a decade
  • Mid-America is seen as a solid investment with a 2-3 year time horizon
  • Company owns over 100,000 apartment units in Sunbelt cities, trades at 6.8% cap rate, and has a free cash flow yield of 6.5% to 7.0%, expected to grow over time

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Morning Views Asia: China Jinmao Holdings

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Kawasaki Heavy Industries, Yaoko Co Ltd, Skymark Airlines, Tokyo Stock Exchange Tokyo Price Index Topix and more

By | Daily Briefs, Japan

In today’s briefing:

  • Kawasaki Heavy (7012) | Hydrogen Strategy Ignites Stock Market
  • Yaoko: 34 Years of Record Profits
  • Skymark Airlines Lockup Expiry – Still Doesn’t Seem Cheap with 50% of the Shares Being Unlocked
  • Diversity and Human Rights Are Also Challenges in Solving the Problem of Population Decline


Kawasaki Heavy (7012) | Hydrogen Strategy Ignites Stock Market

By Mark Chadwick

  • Japan’s newly approved hydrogen strategy has ignited a stock market rally in related names: KHI (+20%) Iwatani (+15%) Kansai Elec (+2%)
  • Japan government approved higher supply targets for hydrogen to bring the hydrogen strategy in line with the most recent energy mix targets
  • Kawasaki Heavy Industries plays a key role in Japan’s hydrogen supply chain, specializing in liquefied hydrogen and innovative initiatives

Yaoko: 34 Years of Record Profits

By Michael Causton

  • One of the few long-term success stories in supermarkets is Yaoko, which recently celebrated 34 consecutive years of record operating profits. 
  • Thanks to a combination of innovation and attention to detail, Yaoko’s financial performance continues to trounce larger rivals in the highly competitive food market in Kanto.
  • With Japan’s supermarket sector about to enter a period of consolidation, Yaoko will be one of the leaders.

Skymark Airlines Lockup Expiry – Still Doesn’t Seem Cheap with 50% of the Shares Being Unlocked

By Ethan Aw

  • Skymark Airlines (9204 JP) raised US$242m in its Japan IPO. The shares began to trade on 14th Dec 2022, its six-month lockup will expire on 11th Jun 2023.
  • Skymark Airlines (SA) is a Japanese low-cost airline, being the third largest domestic airline  according to the company. Unlike major airlines and other low-cost carriers, Skymark operates only domestic flights.
  • In this note, we will talk about the lock-up dynamics and updates since our last note.

Diversity and Human Rights Are Also Challenges in Solving the Problem of Population Decline

By Aki Matsumoto

  • Population decline is not far in the future, and a situation is looming where rural municipalities will no longer be able to function to support social infrastructure.
  • The government is sticking to maintain the foreign technical internship in industries where labor is in short supply, and managing the number of foreign workers accepted for 5-10 year time-limit.
  • Accepting foreigners means that people must live in a society that recognizes diversity and each other’s human rights. Unfortunately, we are not ready to create such a society.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Canvest Environmental Protection Group, Timee Inc, Luxshare Precision Industry, GoodWe Technologies , Cathay Pacific Airways, Dobot, S.F. Holding and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Canvest Environmental (1381 HK): Possible Privatisation at HK$4.90
  • Timee (215A JP) IPO: Valuation Insights
  • Timee Pre-IPO – Thoughts on Valuation – Primed for a Decent Upside at the Current Range
  • Mainland Connect NORTHBOUND Flows (To 5 July 2024): Finance, Consumer, IT Sold, Utilities Bought
  • STAR100 Index Rebalance Preview: Outright Adds Outperforming Outright Deletes
  • Cathay Pacific (293 HK, BUY, TP:HKD):
  • Shenzhen Yuejiang Technology IPO Preview: Dobot Files to List IPO on Hong Kong Stock Exchange
  • SF Holding Pre-IPO: Core EBITDA Margins Compare Favorably to Most Express Peers in China and US


Canvest Environmental (1381 HK): Possible Privatisation at HK$4.90

By Arun George

  • Grandblue Environment Co A (600323 CH) disclosed a potential pre-conditional privatisation of Canvest Environmental Protection Group (1381 HK) at HK$4.90 per share, a 20.7% premium to the last close price. 
  • Completing the capital injection from SOE entities into the offeror is a precondition. Grandblue also proposes that the controlling shareholder roll over 7.23% of its effective 44.75% stake. 
  • While not a knockout bid, the offer is reasonable. Shareholders with blocking stakes should support a binding proposal. Timing is the key risk. 

Timee (215A JP) IPO: Valuation Insights

By Arun George


Timee Pre-IPO – Thoughts on Valuation – Primed for a Decent Upside at the Current Range

By Clarence Chu

  • Timee Inc (215A JP) is looking to raise US$290m in its Japan IPO. The IPO will be a 100% secondary selldown by existing shareholders.
  • Timee operates an on-demand staffing platform that connects part-time jobseekers with businesses in Japan.
  • In an earlier note, we looked at the firm’s past performance and peer comparison. In this note, we discuss our thoughts on valuation.

Mainland Connect NORTHBOUND Flows (To 5 July 2024): Finance, Consumer, IT Sold, Utilities Bought

By Travis Lundy

  • The Quiddity Mainland Connect NORTHBOUND Monitor. Like the A/H Premium Monitor and HK Connect SOUTHBOUND Monitor. Lots of Flows/Position Tables and Charts with which to play.
  • Last week saw NORTHBOUND net SELL RMB 13.9bn of A-shares. NORTHBOUND bought utilities and raw materials and sold everything else, especially consumer names. Appliances remain on the sell side.
  • It is notable that net flows as a percentage of value traded are clearly “short gamma”, which is to say, sector underperformers are being sold, not bought.

STAR100 Index Rebalance Preview: Outright Adds Outperforming Outright Deletes

By Brian Freitas

  • The review period for the September rebalance ends 30 July. We expect the changes to be announced 30 August with the implementation taking place after the close on 13 September.
  • We forecast 6 changes for the index, including migrations between the STAR 100 Index and the SSE STAR50 (STAR50 INDEX).
  • Excluding the migrations, the potential adds have outperformed the potential deletes since the start of the calendar year and there could be further outperformance over the next few weeks.

Cathay Pacific (293 HK, BUY, TP:HKD):

By Mohshin Aziz

  • Operations are on track with earlier guidance given during FY23 results, loads and yields are healthy, with UK and North American performing better than expected  
  • Will buyback and cancel remaining 97.7m preference shares for a sum of HKD10b by end of July 2024. Shareholder dilution has been avoided  
  • Cathay Pacific is a value BUY, our target price of HK$9.90 (+24% UPSIDE) implies 10x FY2024 PE, parity multiple against its arch-rival Singapore Airlines (SIA SP) 

Shenzhen Yuejiang Technology IPO Preview: Dobot Files to List IPO on Hong Kong Stock Exchange

By Andrei Zakharov

  • Shenzhen Yuejiang Technology (Dobot), a China-based cobot company, filed for a Hong Kong IPO. Cobots are robots with operational robotic arms intended for collaboration within a shared space.
  • Dobot was backed by CICC, CRRC VC, Greenpine Growth, Qianhai Equity, and China Internet Investment Fund, among others. The company was founded in 2015 in Shenzhen, PRC.
  • The offering may attract significant investor interest after South Korea’s robotics company Doosan Robotics could raise ~$318M in October 2023.

SF Holding Pre-IPO: Core EBITDA Margins Compare Favorably to Most Express Peers in China and US

By Daniel Hellberg

  • We believe SF’s core express margins are higher than most of its peers’ margins
  • But on 2023 EV / EBITDA SF trades at multiples below most Chinese, US peers
  • One objective of SF listing in HK is to attract global investors, lift valuation

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Energy/Materials: Rex Minerals, Copper, Mongolian Mining and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • Rex Minerals (RXM AU)’s Scheme With The Salim Group
  • Copper Tracker July 2024: Physical/​Equity Screens And Trades
  • Mongolia Mining Corp (975 HK): Play on Coking Coal Price With Growth Optionality


Rex Minerals (RXM AU)’s Scheme With The Salim Group

By David Blennerhassett

  • Copper-Gold play Rex Minerals (RXM AU) has entered into a Scheme with MACH Australia.
  • MACH, wholly-owned by Indonesia’s Salim Group, is offering A$0.47/share in cash, a 71% premium to last close and a decade-high.
  • Rex shareholder approval and FIRB are the key conditions. Rex’s board is unanimously supportive. This Offer will tentatively complete late October.

Copper Tracker July 2024: Physical/​Equity Screens And Trades

By Sameer Taneja


Mongolia Mining Corp (975 HK): Play on Coking Coal Price With Growth Optionality

By Sameer Taneja


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: Silergy Corp, Vanguard Intl Semiconductor and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • Silergy (6415.TT): Trial-Run with Vanguard, and Recent Stock Drops Represent an Entry Opportunity.
  • Vanguard (5347.TT): The Utilization to Improve over 70% in 3Q24.


Silergy (6415.TT): Trial-Run with Vanguard, and Recent Stock Drops Represent an Entry Opportunity.

By Patrick Liao

  • We are surprised that Silergy Corp (6415 TT) is using Vanguard Intl Semiconductor (5347 TT) to trial-run products.
  • The outlook for 2024 remains unchanged at over 20% YoY, and we still see a path to recovery ahead.
  • We consider the recent drop from NTD$526 on June 14th to NTD$429 on July 5th as an opportunity to consider entering the stock.

Vanguard (5347.TT): The Utilization to Improve over 70% in 3Q24.

By Patrick Liao


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Canvest Environmental Protection Group, Timee Inc, Luxshare Precision Industry, GoodWe Technologies , Cathay Pacific Airways, Dobot, S.F. Holding and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Canvest Environmental (1381 HK): Possible Privatisation at HK$4.90
  • Timee (215A JP) IPO: Valuation Insights
  • Timee Pre-IPO – Thoughts on Valuation – Primed for a Decent Upside at the Current Range
  • Mainland Connect NORTHBOUND Flows (To 5 July 2024): Finance, Consumer, IT Sold, Utilities Bought
  • STAR100 Index Rebalance Preview: Outright Adds Outperforming Outright Deletes
  • Cathay Pacific (293 HK, BUY, TP:HKD):
  • Shenzhen Yuejiang Technology IPO Preview: Dobot Files to List IPO on Hong Kong Stock Exchange
  • SF Holding Pre-IPO: Core EBITDA Margins Compare Favorably to Most Express Peers in China and US


Canvest Environmental (1381 HK): Possible Privatisation at HK$4.90

By Arun George

  • Grandblue Environment Co A (600323 CH) disclosed a potential pre-conditional privatisation of Canvest Environmental Protection Group (1381 HK) at HK$4.90 per share, a 20.7% premium to the last close price. 
  • Completing the capital injection from SOE entities into the offeror is a precondition. Grandblue also proposes that the controlling shareholder roll over 7.23% of its effective 44.75% stake. 
  • While not a knockout bid, the offer is reasonable. Shareholders with blocking stakes should support a binding proposal. Timing is the key risk. 

Timee (215A JP) IPO: Valuation Insights

By Arun George


Timee Pre-IPO – Thoughts on Valuation – Primed for a Decent Upside at the Current Range

By Clarence Chu

  • Timee Inc (215A JP) is looking to raise US$290m in its Japan IPO. The IPO will be a 100% secondary selldown by existing shareholders.
  • Timee operates an on-demand staffing platform that connects part-time jobseekers with businesses in Japan.
  • In an earlier note, we looked at the firm’s past performance and peer comparison. In this note, we discuss our thoughts on valuation.

Mainland Connect NORTHBOUND Flows (To 5 July 2024): Finance, Consumer, IT Sold, Utilities Bought

By Travis Lundy

  • The Quiddity Mainland Connect NORTHBOUND Monitor. Like the A/H Premium Monitor and HK Connect SOUTHBOUND Monitor. Lots of Flows/Position Tables and Charts with which to play.
  • Last week saw NORTHBOUND net SELL RMB 13.9bn of A-shares. NORTHBOUND bought utilities and raw materials and sold everything else, especially consumer names. Appliances remain on the sell side.
  • It is notable that net flows as a percentage of value traded are clearly “short gamma”, which is to say, sector underperformers are being sold, not bought.

STAR100 Index Rebalance Preview: Outright Adds Outperforming Outright Deletes

By Brian Freitas

  • The review period for the September rebalance ends 30 July. We expect the changes to be announced 30 August with the implementation taking place after the close on 13 September.
  • We forecast 6 changes for the index, including migrations between the STAR 100 Index and the SSE STAR50 (STAR50 INDEX).
  • Excluding the migrations, the potential adds have outperformed the potential deletes since the start of the calendar year and there could be further outperformance over the next few weeks.

Cathay Pacific (293 HK, BUY, TP:HKD):

By Mohshin Aziz

  • Operations are on track with earlier guidance given during FY23 results, loads and yields are healthy, with UK and North American performing better than expected  
  • Will buyback and cancel remaining 97.7m preference shares for a sum of HKD10b by end of July 2024. Shareholder dilution has been avoided  
  • Cathay Pacific is a value BUY, our target price of HK$9.90 (+24% UPSIDE) implies 10x FY2024 PE, parity multiple against its arch-rival Singapore Airlines (SIA SP) 

Shenzhen Yuejiang Technology IPO Preview: Dobot Files to List IPO on Hong Kong Stock Exchange

By Andrei Zakharov

  • Shenzhen Yuejiang Technology (Dobot), a China-based cobot company, filed for a Hong Kong IPO. Cobots are robots with operational robotic arms intended for collaboration within a shared space.
  • Dobot was backed by CICC, CRRC VC, Greenpine Growth, Qianhai Equity, and China Internet Investment Fund, among others. The company was founded in 2015 in Shenzhen, PRC.
  • The offering may attract significant investor interest after South Korea’s robotics company Doosan Robotics could raise ~$318M in October 2023.

SF Holding Pre-IPO: Core EBITDA Margins Compare Favorably to Most Express Peers in China and US

By Daniel Hellberg

  • We believe SF’s core express margins are higher than most of its peers’ margins
  • But on 2023 EV / EBITDA SF trades at multiples below most Chinese, US peers
  • One objective of SF listing in HK is to attract global investors, lift valuation

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: China Traditional Chinese Medicine, Shanghai Henlius Biotech and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Merger Arb Mondays (08 Jul) – China TCM, L’Occitane, A8 Media, GA Pack, Asia Cement, Hollysys, MMA
  • Shanghai Henlius Biotech Update (2696.HK) – The Story Behind Privatization



Shanghai Henlius Biotech Update (2696.HK) – The Story Behind Privatization

By Xinyao (Criss) Wang

  • Fosun’s preferred arrangement for Henlius is to list the Company in A-shares.Since IPO in A-shares failed and Henlius has begun to generate profits, Fosun finally feels the need for privatization.
  • Due to its “flaws”, undervaluation of Henlius in the Hong Kong stock market is difficult to fundamentally change. So, for conservative/cautious investors, Fosun’s one-time acquisition at a 30% premium is attractive.
  • The Potential Share Alternative Offer seems a good option, but it is uncertain whether investors are still willing to believe in Fosun’s “good story” – the future re-listing is uncertain.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: TSE Tokyo Price Index TOPIX, Zip , ICBC (H), NIFTY Index, Greentown China and more

By | Daily Briefs, Financials

In today’s briefing:

  • Fy23 GPIF Results and Portfolio Changes – Outlook for FY24
  • S&P/ASX 100/200 Index Adhoc Rebalance: Potential Replacements for Altium (ALU AU)
  • HK Connect SOUTHBOUND Flows (To 5 Jul 2024); SOE Bank and SOE Petro-Energy Flows Dominate
  • EQD / NSE Vol Update / Regular Correlations Take Hold – Vols Drop as Market Soars
  • Morning Views Asia: Greentown China, NagaCorp Ltd, Vedanta Resources, Yuexiu Property


Fy23 GPIF Results and Portfolio Changes – Outlook for FY24

By Travis Lundy

  • Last year, the GPIF as a whole returned 22.67% in yen terms. As a whole, GPIF outperformed its benchmarks by 0.04% after paying 0.02% in fees and costs.
  • GPIF traded ¥30trln of assets – relatively high turnover for a fund which espouses very low turnover – but there’s a reason for that. There were also sharp active/passive moves.
  • This year is the last year in the “cycle” of the “old” Policy Allocation Framework. A new one is likely to be introduced this year.

S&P/ASX 100/200 Index Adhoc Rebalance: Potential Replacements for Altium (ALU AU)

By Brian Freitas

  • With all regulatory approvals received, the Scheme Meeting for Renesas Electronics (6723 JP)‘ acquisition of Altium Ltd (ALU AU) will take place on 12 July.
  • If approved at the Scheme Meeting and at the Second Court Hearing, Altium Ltd (ALU AU) will stop trading from the close on 19 July.
  • The replacements for Altium Ltd (ALU AU) in the ASX100/200 indices could be announced late this week with implementation at the close on 19 July.

HK Connect SOUTHBOUND Flows (To 5 Jul 2024); SOE Bank and SOE Petro-Energy Flows Dominate

By Travis Lundy

  • SOUTHBOUND was again a net buyer, for HK$10.9bn this week, on smallish two-way volumes. Banks were a big buy.
  • The more I watch, the more I think the last few months have had serious national team buying of banks and energy, perhaps ahead of shareholder return policy changes.
  • But valuations are acceptable. Flows are good. Policy changes are afoot. SOUTHBOUND may continue to see inflows – national team and otherwise.

EQD / NSE Vol Update / Regular Correlations Take Hold – Vols Drop as Market Soars

By Sankalp Singh

  • Regular Spot-Vol Correlations reasserted – Implied Volatilities (IVs) traded lower as Equity Markets continued making new Highs.
  • As expected, Vol-Regime Switching Model is stuck in “High & Down” state. IVs projected to grind lower over an elongated period.      
  • Changes in Vol term-structure + Skew/ Smile compression – indicative of reduced risk-premia for July-end India Budget event.

Morning Views Asia: Greentown China, NagaCorp Ltd, Vedanta Resources, Yuexiu Property

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: SHEIN, Toyota Motor, Clio Cosmetics, TSE Tokyo Price Index TOPIX, BYD, Corn Active Contract, Card Factory and more

By | Consumer, Daily Briefs

In today’s briefing:

  • SHEIN/Temu/AliExpress: As US Mulls Reforming “De Minimis” Rules, EU Could Take Similar Action
  • ECM Weekly (8th July 2024) – Japan Cross-Shareholding, Honda, Aisin, Timee, Chenqi, Cirrus, Emcure
  • KOSDAQ150 Index Rebalance Preview: For Now, A Dozen Changes in December
  • The Key to Higher ROE Is Higher Profit Margins and Faster Efforts by Smaller Companies
  • China Consumption Weekly (8 Jul 2024): BYD, Seres, Tesla, Microsoft, XHS, Mixue
  • Crop Prices Plunge as Favorable US Weather Accelerates Planting, Growth, & Harvesting
  • Card Factory (CARD) – Sunday, Apr 7, 2024


SHEIN/Temu/AliExpress: As US Mulls Reforming “De Minimis” Rules, EU Could Take Similar Action

By Daniel Hellberg

  • EU, like the US, is considering lowering “de minimis” import threshold, soon
  • Lowering import value thresholds or raising reporting requirements could make SHEIN/Temu/AliExpress goods more expensive, and fulfillment more onerous
  • Threat of “de minimis” changes coming just as SHEIN reportedly seeks an IPO

ECM Weekly (8th July 2024) – Japan Cross-Shareholding, Honda, Aisin, Timee, Chenqi, Cirrus, Emcure

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, we looked at the recently launced offerings of Timee Inc , Chenqi Technology Limited and Cirrus Aircraft.
  • On the placement front, this week too was dominated by the cross-shareholding unwinds, this time in Honda Motor (7267 JP).

KOSDAQ150 Index Rebalance Preview: For Now, A Dozen Changes in December

By Brian Freitas

  • With just over a third of the review period complete, there could be 12 changes for the KOSDAQ 150 Index (KOSDQ150 INDEX EQUITY) at the December rebalance.
  • Even with 12 potential changes, there is sector balance with over half the changes in the Information Technology sector. Passive trading impact varies from 0.04-4.1x ADV.
  • The potential adds have outperformed the potential deletes and the KOSDAQ 150 Index (KOSDQ150 INDEX) since the start of the year with a big move higher since mid-May.

The Key to Higher ROE Is Higher Profit Margins and Faster Efforts by Smaller Companies

By Aki Matsumoto

  • Since TSE’s request, more companies have used ROE or ROIC as KPIs in mid-term management plans, but even now, more companies only indicate targets for sales, operating profit, etc.
  • Larger companies have been the first to raise ROE; the key will be for smaller companies, which have been slower to improve their ROE, to raise their ROE.
  • Many companies have only just begun to reduce their policy shareholdings and strengthen shareholder returns, and are still in the process of addressing the core issue of increasing profit margins.

China Consumption Weekly (8 Jul 2024): BYD, Seres, Tesla, Microsoft, XHS, Mixue

By Ming Lu

  • BYD’s sales volume increased by 35% YoY in June and by 39% YoY in 2Q24.
  • Tesla’s Model Y is on the state-owned corporation procurement catalogs.
  • Microsoft plans to close its franchised store chain in China due to the weak demand for Surface.

Crop Prices Plunge as Favorable US Weather Accelerates Planting, Growth, & Harvesting

By Srinidhi Raghavendra

  • Corn and Wheat planted acreage are down 3% and 5% YoY, respectively. Meanwhile, Soybean total planted area is up by 5% YoY compared to 2023.
  • Planted acreage and ending stocks drove prices down for wheat and corn. Soybeans bucked the trend as reported acreage fell short of WASDE estimates by 400k acres.
  • A positive picture for 2024 planting season is visible, with the early benefits of warm temperatures and improved moisture levels setting the stage for strong yields.

Card Factory (CARD) – Sunday, Apr 7, 2024

By Value Investors Club

  • CARD is a UK microcap retailer with impressive qualities despite appearing unattractive at first glance
  • The company has shown consistent growth and gains market share each year in a stagnant market
  • With a strong balance sheet, high return on capital employed, and efficient CEO, CARD presents a compelling investment opportunity at a low valuation

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars